Relationships between alanine aminotransferase levels, abnormal liver echogenicity, and metabolic syndrome

Journal of the American Board of Family Medicine

Volumn 24, Issue 4, 2011, Pages 407-414

  Hsu, Chun Hsien ^a   Wang, Jen Yu ^a   Chen, Yen Lin ^a   Liu, Chuan Chieh ^a   Chang, Yen Lin ^a   Chen, Hsiao Shuang ^a   Pei, Chun ^b   Pei, Dee ^a  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b NAN KAI UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

Alanine aminotransferase; Geriatrics; Liver echogenicity; Metabolic syndrome; Taiwan

Indexed keywords

ALANINE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABNORMAL LIVER ECHOGENICITY; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; RISK;

AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; CROSS-SECTIONAL STUDIES; HUMANS; INCIDENCE; LIVER; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 79960191125     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2011.04.100267     Document Type: Article

References (26)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28. (Pubitemid 40523737)
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
4. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112:2735-52. (Pubitemid 41532612)
5. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004;27:1182-6.
6. Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 2006;105:626-35.
7. Ohlson LO, Larsson B, Bjorntorp P, et al. Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 1988;31:798-805.
8. Mainous AG 3rd, Diaz VA, King DE, Everett CJ, Player MS. The relationship of hepatitis antibodies and elevated liver enzymes with impaired fasting glucose and undiagnosed diabetes. J Am Board Fam Med 2008;21:497-503.
9. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844-50. (Pubitemid 33641605)
10. Tchelepi H, Ralls PW, Radin R, Grant E. Sonography of diffuse liver disease. J Ultrasound Med 2002;21:1023-32. (Pubitemid 34988610)
11. Vehmas T, Kaukiainen A, Immonen-Raiha P, Lohman M, Luoma K. Liver echogenicity: relation to systemic blood pressure and other components of the metabolic syndrome. Ultrasound Med Biol 2005;31:293-9. (Pubitemid 40327214)
12. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986;292:13-5. (Pubitemid 16175875)
13. Sattar N, Scherbakova O, Ford I, et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes 2004;53:2855-60. (Pubitemid 39425910)
14. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB, Haffner SM. Liver markers and development of the metabolic syndrome. Diabetes 2005;54:3140-7.
15. Kim HC, Choi SH, Shin HW, et al. Severity of ultrasonographic liver steatosis and metabolic syndrome in Korean men and women. World J Gastroenterol 2005;11:5314-21. (Pubitemid 41410298)
16. Shen YH, Yang WS, Lee TH, Lee LT, Chen CY, Huang KC. Bright liver and alanine aminotransferase are associated with metabolic syndrome in adults. Obes Res 2005;13:1238-45.
17. Olynyk JK, Knuiman MW, Divitini ML, Davis TME, Beilby J, Hung J. Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population. Am J Gastroenterol 2009;104:1715-22.
18. Chen DS. Hepatocellular carcinoma in Taiwan. Hepatol Res 2007;37:S101-S5.
19. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:960-7. (Pubitemid 36733754)
20. Mofrad P, Contos MJ, Haque M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003;37:1286-92. (Pubitemid 36667307)
21. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-23. (Pubitemid 36397405)
22. Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28:27-38.
23. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387-95. (Pubitemid 39657013)
24. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991;43:26-31.
25. Hsu CS, Kao JH. Hepatitis C infection and metabolic syndrome. J Formos Med Assoc 2010;109:403-7.
26. Sheikh MY, Choi J, Qadri I, Friedman JE, Sanyal AJ. Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology 2008;47:2127-33. (Pubitemid 351945577)